Rongrong Zhang

Rongrong Zhang is a distinguished professional in health economics and outcomes research (HEOR), currently serving as Associate Director of Market Access and HEOR at Incyte since November 2025. Previously, Rongrong held the position of Senior Manager for Global HEOR at PTC Therapeutics, where leadership encompassed global HEOR initiatives aimed at enhancing value demonstration and market access strategies for rare disease therapies. With extensive experience in supporting HTA submissions and economic modeling across various therapeutic areas, including AADC deficiency, Duchenne muscular dystrophy, and phenylketonuria, Rongrong's expertise spans over 20 countries worldwide. Rongrong's career includes roles at Boston Scientific as Global HEOR Manager, Consultant at IQVIA, HEOR Consultant at AbbVie, and Associate Evidence Synthesis Consultant at Synergus AB. Academic credentials include dual Master of Medical Science degrees from Karolinska Institutet in Health Economics, Policy and Management, and Bioentrepreneurship, in addition to a Bachelor of Science in Pharmaceutics from Nanjing Tech University.